STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: "I am very pleased to welcome Eric Quéméneur to Transgene. He has extensive experience effectively leading life sciences research teams and ...
TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...
STRASBOURG, France & UTRECHT, The Netherlands–(BUSINESS WIRE)–$TNG–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops ...
Strasbourg, France, September 10, 2024, 7 : 30 AM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased ...
STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies against cancers and infectious diseases, signed a ...
Transgene Biotek Limited is an India-based biotechnology company. It is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback